Effect of Multiple Serine/Alanine Mutations in the Transmembrane Spanning Region V of the D2 Dopamine Receptor on Ligand Binding
Open Access
- 1 January 2000
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 74 (1) , 358-366
- https://doi.org/10.1046/j.1471-4159.2000.0740358.x
Abstract
Three conserved serine residues (Ser193, Ser194, and Ser197) in transmembrane spanning region (TM) V of the D2 dopamine receptor have been mutated to alanine, individually and in combination, to explore their role in ligand binding and G protein coupling. The multiple Ser → Ala mutations had no effect on the binding of most antagonists tested, including [3H]spiperone, suggesting that the multiple mutations did not affect the overall conformation of the receptor protein. Double or triple mutants containing an Ala197 mutation showed a decrease in affinity for domperidone, whereas Ala193 mutants showed an increased affinity for a substituted benzamide, remoxipride. However, dopamine showed large decreases in affinity (>20‐fold) for each multiple mutant receptor containing the Ser193 Ala mutation, and the high‐affinity (coupled) state of the receptor (in the absence of GTP) could not be detected for any of the multiple mutants. A series of monohydroxylated phenylethylamines and aminotetralins was tested for their binding to the native and multiple mutant D2 dopamine receptors. The results obtained suggest that Ser193 interacts with the hydroxyl of S‐5‐hydroxy‐2‐dipropylaminotetralin (OH‐DPAT) and Ser197 with the hydroxyl of R‐5‐OH‐DPAT. We predict that Ser193 interacts with the hydroxyl of R‐7‐OH‐DPAT and the 3‐hydroxyl (m‐hydroxyl) of dopamine. Therefore, the conserved serine residues in TMV of the D2 dopamine receptor are involved in hydrogen bonding interactions with selected antagonists and most agonists tested and also enable agonists to stabilise receptor‐G protein coupling.Keywords
This publication has 11 references indexed in Scilit:
- Amino acids of the α1B‐adrenergic receptor involved in agonist binding: differences in docking catecholamines to receptor subtypesFEBS Letters, 1996
- 7TM receptors: 'locks' and 'keys'?Trends in Pharmacological Sciences, 1996
- The Unique Nature of the Serine Interactions for α1-Adrenergic Receptor Agonist Binding and ActivationPublished by Elsevier ,1996
- Investigation of the Role of Conserved Serine Residues in the Long Form of the Rat D2 Dopamine Receptor Using Site‐Directed MutagenesisJournal of Neurochemistry, 1996
- Residues in the Fifth Membrane-Spanning Segment of the Dopamine D2 Receptor Exposed in the Binding-Site CreviceBiochemistry, 1995
- Identification of Critical Determinants of α1-Adrenergic Receptor Subtype Selective Agonist BindingPublished by Elsevier ,1995
- Structural Studies on D2 Dopamine Receptors: Mutation of a Histidine Residue Specifically Affects the Binding of a Subgroup of Substituted Benzamide DrugsJournal of Neurochemistry, 1994
- Site-directed mutagenesis of the human dopamine D2 receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation.Journal of Biological Chemistry, 1992
- Contributions of Conserved Serine Residues to the Interactions of Ligands with Dopamine D2 ReceptorsJournal of Neurochemistry, 1992